Compass Point has initiated coverage on Circle Internet Group Inc . (NYSE:CRCL) with a “neutral” rating and a $205 price target, citing both its leadership in regulated stablecoins and challenges in ...

Compass Pathways' Phase 3 COMP-360 data met primary endpoints but disappointed vs analyst expectations. See why investors ...

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

Compass Pathways plc downgraded to Hold after mixed trial results. Explore upcoming catalysts in depression treatment and ...

Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.

Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

Compass Pathways' COMP005 trial met its primary endpoint in TRD, but modest results sparked a 47% drop in shares amid ...

The 18-year-old wasn’t ranked in the top-50 in his class, joined Oklahoma a year early and led the Sooners to the NCAA ...

Compass Point highlighted USDC’s leading technology and liquidity as long-term advantages for Circle. However, the firm emphasized that distribution is a key driver of stablecoin market share, ...